August J. Moretti - 15 May 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Financial Officer
Signature
/s/ August J. Moretti
Issuer symbol
FDMT
Transactions as of
15 May 2023
Net transactions value
+$28,230
Form type
4
Filing time
16 May 2023, 20:52:00 UTC
Previous filing
14 Feb 2023
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise $28,230 +3,000 +37% $9.41 11,045 15 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Options Exercise $0 -3,000 -1.4% $0.000000 217,060 15 May 2023 Common Stock 3,000 $9.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 1,450 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
F2 The option is fully vested and exercisable